Rhumbline Advisers Applied Therapeutics Inc. Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 129,700 shares of APLT stock, worth $51,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

129,700

Previous 134,335 3.45%

Holding current value

$51,880

Previous $114,000 41.23%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$0.46 - $0.94 $2,132 - $4,356	-4,635 Reduced 3.45%	129,700 $67,000
Q4 2024 Jan 30, 2025	BUY	$0.82 - $10.24 $810 - $10,117	988 Added 0.74%	134,335 $114,000
Q3 2024 Nov 12, 2024	SELL	$4.35 - $8.5 $2,383 - $4,658	-548 Reduced 0.41%	133,347 $1.13 Million
Q2 2024 Aug 01, 2024	BUY	$4.04 - $6.37 $538,738 - $849,445	133,351 Added 24513.05%	133,895 $625,000
Q2 2023 Aug 08, 2023	BUY	$0.77 - $1.8 $418 - $979	544 New	544 $0
Q2 2022 Aug 11, 2022	SELL	$0.76 - $2.64 $13,230 - $45,959	-17,409 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.48 - $6.22 $1,044 - $4,391	-706 Reduced 3.9%	17,409 $37,000
Q4 2021 Feb 10, 2022	SELL	$8.77 - $18.29 $2,815 - $5,871	-321 Reduced 1.74%	18,115 $162,000
Q3 2021 Nov 12, 2021	BUY	$13.54 - $22.06 $11,170 - $18,199	825 Added 4.68%	18,436 $306,000
Q2 2021 Aug 05, 2021	BUY	$14.05 - $25.04 $26,259 - $46,799	1,869 Added 11.87%	17,611 $366,000
Q1 2021 May 06, 2021	SELL	$16.57 - $28.65 $2,651 - $4,584	-160 Reduced 1.01%	15,742 $295,000
Q4 2020 Feb 10, 2021	BUY	$15.44 - $24.23 $15,440 - $24,230	1,000 Added 6.71%	15,902 $350,000
Q3 2020 Nov 12, 2020	SELL	$19.43 - $35.36 $28,950 - $52,686	-1,490 Reduced 9.09%	14,902 $309,000
Q2 2020 Aug 13, 2020	BUY	$29.41 - $51.23 $253,602 - $441,756	8,623 Added 110.99%	16,392 $593,000
Q1 2020 May 06, 2020	BUY	$19.54 - $55.47 $151,806 - $430,946	7,769 New	7,769 $254,000

Others Institutions Holding APLT

# of Institutions

131

Shares Held

111M

Call Options Held

1.1M

Put Options Held

800K

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $19.2M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Applied Therapeutics Inc. Transaction History